Vizgen will expand applications of MERSCOPE Ultra™ platform to include spatially-resolved molecular profiling of organoids; company has expansive pipeline and is progressing toward multiple breakthrough capabilities WALTHAM, Mass. — Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease […]
New chemistry reduces barriers to scaling single-cell studies across research settings SEATTLE — Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading provider of scalable and accessible single cell sequencing solutions today announced the launch of the new Evercode™ Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity, and […]
BOSTON — Stellaromics today launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100 micrometers thick. The launch marks a fundamental shift in spatial biology — from 2D thin-section approaches that analyze partial cell layers to true 3D analysis that preserves the native organization of cells, molecules, […]
CAMBRIDGE, England — Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to substantially lower the price per vial of its ioCells™ portfolio. This initiative is further strengthened by the launch of bit.bio’s second dedicated distribution hub, expanding on its […]
Company to showcase highly scalable and versatile capsule technology at the AGBT 2026 General Meeting ORLANDO, Fla. — Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced the launch of its new 170 µm and 300 µm SPC Innovator Kits, the company’s most versatile SPC generation kits to date. Designed for encapsulating a […]
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models Strengthens position as the leading independent provider of physiologically-relevant in vitro retinal models for ophthalmology drug discovery and safety testing Cambridge, UK and Newcastle, UK — Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug […]
ATLANTA, GA — Axion BioSystems today announced that the FDA’s Center for Drug Evaluation and Research (CDER) has accepted the company’s letter of intent (LOI) into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Program for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular Repolarization Risk. The submission represents the first stem cell-derived, […]
SAN DIEGO — Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced the commercial launch and U.S. availability of G4X. The launch marks a major milestone in making large-scale spatial multiomics accessible for translational research, spatial pathology, and AI-driven insights. The G4X platform enables simultaneous analysis of 500-plex RNA, 18-plex protein and fH&E […]
STOCKHOLM, Sweden — CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and […]
Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential. Using a simple 3-step process of media changes and cell passaging – these advanced kits can typically achieve 70% MF20-positive myotubes. The highly efficient protocol employed by the kit does not require genetic intervention or cell sorting, […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
